Which treatment modality is not typically associated with Bell's Palsy management?

In the management of Bell's Palsy, various treatment modalities are recognized for their effectiveness in alleviating symptoms and promoting recovery. Among the options provided, intravenous immunoglobulin therapy is not typically used in the treatment of Bell's Palsy.

Bell's Palsy often results from viral infections leading to inflammation of the facial nerve. The primary goal of treatment is to reduce inflammation and help restore facial function. Corticosteroids, for instance, are commonly administered to decrease inflammation and improve recovery time. Heat therapy can also be beneficial for pain management, as it helps relax the facial muscles and alleviate discomfort.

Facial muscle exercises may be recommended to maintain muscle tone and promote recovery of facial function, making them a relevant part of rehabilitation in some cases.

In contrast, intravenous immunoglobulin therapy is mainly utilized for different conditions such as certain autoimmune diseases and chronic inflammatory demyelinating polyneuropathy. It is not a standard treatment for Bell's Palsy, as there is insufficient evidence supporting its use for this specific condition. This lack of association with Bell's Palsy management clearly distinguishes it as the correct answer.